Hakutulokset

Aihe-ehdotuksia
Tarkenna hakua
  1. 1
    Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy

    Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy Tekijä A. Y. Wong, Michael G. Irwin, T. W. C. Hui, Serena K. Y. Fung, Sheung Tat Fan, Edmond S.K.

    Julkaistu 2003
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Desmopressin induces endothelial P-selectin expression and leukocyte rolling in postcapillary venules

    Desmopressin induces endothelial P-selectin expression and leukocyte rolling in postcapillary venules Tekijä Shamsher S. Kanwar, RC Woodman, M‐C. Poon, T Murohara, Lefer Am, KL Davenpeck, Paul Kubes

    Julkaistu 1995
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factor

    DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released... Tekijä Marco Cattaneo, Marco Moia, Paula Valle, Paola Castellana, PM Mannucci

    Julkaistu 1989
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    von Willebrand disease "Vicenza" with larger-than-normal (supranormal) von Willebrand factor multimers

    von Willebrand disease "Vicenza" with larger-than-normal (supranormal) von Willebrand factor multimers Tekijä PM Mannucci, R Lombardi, Giancarlo Castaman, JA Dent, A Lattuada, F Rodeghiero, TS Zimmerman

    Julkaistu 1988
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time

    Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time Tekijä PM Mannucci, Vicente Vicente, L Vianello, Marco Cattaneo, I Alberca, M. P. Coccato, Elena M. Faioni, D Mari

    Julkaistu 1986
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Mild hemophilia A

    Mild hemophilia A Tekijä Massimo Franchini, Emmanuel J. Favaloro, Giuseppe Lippi

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Management of acquired haemophilia A

    Management of acquired haemophilia A Tekijä Peter W. Collins

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Treatment of inherited platelet disorders

    Treatment of inherited platelet disorders Tekijä Uri Seligsohn

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Desmopressin for nocturnal enuresis in children

    Desmopressin for nocturnal enuresis in children Tekijä Cathryn Glazener, Jonathan HC Evans

    Julkaistu 2002
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Desmopressin use for minimising perioperative allogeneic blood transfusion

    Desmopressin use for minimising perioperative allogeneic blood transfusion Tekijä Michael Desborough, Lise J Estcourt, Carolyn Dorée, Marialena Trivella, Simon Stanworth

    Julkaistu 2004
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics)

    Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics) Tekijä Aniruddh Deshpande, Patrina Caldwell, Premala Sureshkumar

    Julkaistu 2012
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    von Willebrand disease: Clinical and laboratory lessons learned from the large von Willebrand disease studies

    von Willebrand disease: Clinical and laboratory lessons learned from the large von Willebrand disease studies Tekijä Paula D. James, David Lillicrap

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: Reduction in blood product usage with desmopressin

    Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: Reduction in blood product usage with desmopressin Tekijä L. Czer, Timothy M. Bateman, Richard J. Gray, Marjorie Raymond, Morgan E. Stewart, Stephen Lee, Dennis Goldfinger, Aurelio Chaux, Jack M. Matloff

    Julkaistu 1987
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    A Combined Test Using Desmopressin and Corticotropin-Releasing Hormone in the Differential Diagnosis of Cushing’s Syndrome

    A Combined Test Using Desmopressin and Corticotropin-Releasing Hormone in the Differential Diagnosis of Cushing’s Syndrome Tekijä John Newell‐Price, Les Perry, Sami Medbak, John P. Monson, Martin O. Savage, Michael Besser, Ashley Grossman

    Julkaistu 1997
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Use of desmopressin (DDAVP) during early pregnancy in factor VIII–deficient women

    Use of desmopressin (DDAVP) during early pregnancy in factor VIII–deficient women Tekijä Pier Mannuccio Mannucci

    Julkaistu 2005
    Hae kokoteksti Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    The Role of Desmopressin Acetate in Patients Undergoing Coronary Artery Bypass Surgery

    The Role of Desmopressin Acetate in Patients Undergoing Coronary Artery Bypass Surgery Tekijä Paul D. Mongan, Michael P. Hosking

    Julkaistu 1992
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis

    Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis Tekijä Allison James, Barbara A. Konkle, Peter A. Kouides, Margaret V. Ragni, Betty Thames, Sweta Gupta, Suman L. Sood, Susan Fletcher, Claire S. Philipp

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    A Cellular and Molecular Basis for the Selective Desmopressin-Induced ACTH Release in Cushing Disease Patients: Key Role of AVPR1b Receptor and Potential Therapeutic Implications

    A Cellular and Molecular Basis for the Selective Desmopressin-Induced ACTH Release in Cushing Disease Patients: Key Role of AVPR1b Receptor and Potential Therapeutic Implications Tekijä Raúl M. Luque, Alejandro Ibáñez‐Costa, Laura M. López‐Sánchez, Luis Jiménez‐Reina, Eva Venegas‐Moreno, María A. Gálvez, Alicia Villa-Osaba, Ainara Madrazo‐Atutxa, Miguel Á. Japón, Andrés de la Riva, David A. Cano, Pedro Benito-López, Alfonso Soto‐Moreno, Manuel D. Gahete, Alfonso Leal‐Cerro, Justo P. Castaño

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia

    Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia Tekijä Åsa Rembratt, A. Riis, Jens Peter Nørgaard

    Julkaistu 2005
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    How I treat patients with von Willebrand disease

    How I treat patients with von Willebrand disease Tekijä Pier Mannuccio Mannucci

    Julkaistu 2001
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: